We are live on
!
Find out more
Natixis Advisors Portfolio holdings
AUM
$71.9B
1-Year Est. Return
28.03%
This Fund
S&P 500
This Quarter
Est. Return
-3.85%
1 Year Est. Return
+28.03%
3 Year Est. Return
+95.12%
5 Year Est. Return
+131.42%
10 Year Est. Return
+475.22%
AUM
$23.6B
AUM Growth
+$900M
(+4%)
Cap. Flow
+$1.81B
Cap. Flow
% of AUM
7.66%
Top 10 Holdings %
Top 10 Hldgs %
15.31%
Holding
1,542
New
90
Increased
818
Reduced
532
Closed
102
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$149M |
| 2 |
Apple
AAPL
|
+$102M |
| 3 |
Amazon
AMZN
|
+$85.4M |
| 4 |
Vanguard Value ETF
VTV
|
+$67.1M |
| 5 |
Microsoft
MSFT
|
+$51M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total Stock Market ETF
VTI
|
+$31.5M |
| 2 |
Nutrien
NTR
|
+$29.5M |
| 3 |
AT&T
T
|
+$28.9M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$27.6M |
| 5 |
Sanofi
SNY
|
+$27.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.61% |
| 2 | Healthcare | 14.15% |
| 3 | Financials | 13.71% |
| 4 | Consumer Discretionary | 9.67% |
| 5 | Industrials | 9.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
LPL Financial
LPLA
$27.4B
| $10.3M | 0.04% |
46,945
+7,256
| +18% | +$1.54M |
|
427
Maravai LifeSciences
MRVI
$1.01B
| $10.2M | 0.04% |
400,781
-24,598
| -6% | -$617K |
|
428
Floor & Decor
FND
$6.14B
| $10.2M | 0.04% |
145,476
+29,056
| +25% | +$2.33M |
|
429
Crown Holdings
CCK
$13.2B
| $10.2M | 0.04% |
125,644
-753
| -0.6% | -$70.2K |
|
430
Exelon
EXC
$48.4B
| $10.1M | 0.04% |
270,457
-130,694
| -33% | -$5.78M |
|
431
Equifax
EFX
$22B
| $10.1M | 0.04% |
58,828
+498
| +0.9% | +$97.6K |
|
432
LKQ Corp
LKQ
$6.77B
| $10M | 0.04% |
212,566
+20,397
| +11% | +$1.07M |
|
433
Idexx Laboratories
IDXX
$44.9B
| $10M | 0.04% |
30,714
-406
| -1% | -$149K |
|
434
Takeda Pharmaceutical
TAK
$56B
| $9.95M | 0.04% |
767,443
+149,114
| +24% | +$2.07M |
|
435
Leidos
LDOS
$14.9B
| $9.95M | 0.04% |
113,737
-29,277
| -20% | -$2.86M |
|
|
HZNP
436
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $9.92M | 0.04% |
160,315
-66,445
| -29% | -$4.64M |
|
|
LAZR
437
DELISTED
Luminar Technologies
LAZR
| $9.89M | 0.04% |
90,507
+30,902
| +52% | +$3.69M |
|
438
Gilead Sciences
GILD
$167B
| $9.83M | 0.04% |
159,387
+22,941
| +17% | +$1.45M |
|
439
EQT Corp
EQT
$32.3B
| $9.82M | 0.04% |
241,096
+121,561
| +102% | +$5.27M |
|
440
VICI Properties
VICI
$29.8B
| $9.75M | 0.04% |
326,550
+68,083
| +26% | +$2.25M |
|
|
EFOR
441
Everforth Inc
EFOR
$953M
| $9.72M | 0.04% |
107,543
-33,164
| -24% | -$3.22M |
|
442
Entergy
ETR
$52.4B
| $9.71M | 0.04% |
192,972
-4,822
| -2% | -$277K |
|
443
Lear
LEA
$7.45B
| $9.68M | 0.04% |
80,903
+21,733
| +37% | +$3M |
|
444
APi Group
APG
$17B
| $9.64M | 0.04% |
1,089,770
+16,362
| +2% | +$174K |
|
445
Vanguard Extended Market ETF
VXF
$30.5B
| $9.61M | 0.04% |
75,589
+11,161
| +17% | +$1.57M |
|
446
Coca-Cola Femsa
KOF
$22.8B
| $9.58M | 0.04% |
164,081
+51,384
| +46% | +$3.06M |
|
447
Prudential
PUK
$36.1B
| $9.55M | 0.04% |
479,248
+5,751
| +1% | +$132K |
|
|
DOOR
448
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $9.53M | 0.04% |
133,715
+3,242
| +2% | +$269K |
|
449
Vanguard FTSE Emerging Markets ETF
VWO
$119B
| $9.52M | 0.04% |
260,875
+58,961
| +29% | +$2.39M |
|
450
Etsy
ETSY
$8.21B
| $9.51M | 0.04% |
94,973
-28,326
| -23% | -$2.89M |
|
Similar funds
BC
Natixis Advisors's Q3 2022 Portfolio in Review
As of Q3 2022, Natixis Advisors held 1,542 positions worth $23.6B, up 4% from $22.7B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Natixis Advisors deployed $1.81B of net new capital in Q3 2022, opening 90 new positions and adding to 818 existing holdings. Its largest new stake was Chemed: 52,930 shares worth $23.1M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Vanguard Total Stock Market ETF, an estimated $31.5M trimmed.
- Natixis Advisors's largest Q3 2022 buy was Chemed: 52,930 shares worth $23.1M.
- Natixis Advisors added most to Vanguard FTSE Developed Markets ETF in Q3 2022, an estimated $149M increase.
- Natixis Advisors's biggest Q3 2022 reduction was Vanguard Total Stock Market ETF, cutting an estimated $31.5M.
- Natixis Advisors fully exited Domino's in Q3 2022, selling an estimated $4.15M.
- Natixis Advisors's ten largest holdings make up 15% of its $23.6B portfolio in Q3 2022.
- Natixis Advisors opened 90 new positions and closed 102 in Q3 2022.
- Natixis Advisors's portfolio value rose 4% quarter-over-quarter to $23.6B.
Based on Natixis Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.